Cargando…
Potential of mesenchymal stem cells alone, or in combination, to treat traumatic brain injury
Traumatic brain injury (TBI) causes death and disability in the United States and around the world. The traumatic insult causes the mechanical injury of the brain and primary cellular death. While a comprehensive pathological mechanism of TBI is still lacking, the focus of the TBI research is concen...
Autores principales: | Willing, Alison E., Das, Mahasweta, Howell, Mark, Mohapatra, Shyam S., Mohapatra, Subhra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248546/ https://www.ncbi.nlm.nih.gov/pubmed/32157822 http://dx.doi.org/10.1111/cns.13300 |
Ejemplares similares
-
Pioglitazone treatment prior to transplantation improves the efficacy of human mesenchymal stem cells after traumatic brain injury in rats
por: Das, Mahasweta, et al.
Publicado: (2019) -
New perspectives on central and peripheral immune responses to acute traumatic brain injury
por: Das, Mahasweta, et al.
Publicado: (2012) -
CCL20-CCR6 axis modulated traumatic brain injury-induced visual pathologies
por: Das, Mahasweta, et al.
Publicado: (2019) -
Lateral fluid percussion injury of the brain induces CCL20 inflammatory chemokine expression in rats
por: Das, Mahasweta, et al.
Publicado: (2011) -
Sertoli Cells Loaded with Doxorubicin in Lipid Micelles Reduced Tumor Burden and Dox-Induced Toxicity
por: Das, Mahasweta, et al.
Publicado: (2017)